SurgePays, Inc. 8-K
Research Summary
AI-generated summary
SurgePays, Inc. Reports Results of 2026 Annual Meeting
What Happened
- SurgePays, Inc. (SURG) filed an 8-K reporting the results of its annual meeting held virtually on June 16, 2026. A total of 17,275,798 shares were present or voted, representing about 68.8% of the 25,121,895 shares outstanding as of the May 5, 2026 record date (quorum achieved).
- All proposals voted at the meeting were approved, including the reelection of four directors (Kevin Brian Cox, David N. Keys, David May, Laurie Weisberg), ratification of TAAD, LLP as the company’s independent registered public accounting firm for fiscal 2026, and approval of the terms of securities purchase agreements with certain institutional investors from 2025–2026 (transactions that involve issuing shares equal to 20% or more of the company’s common stock).
Key Details
- Meeting date: June 16, 2026; Record date: May 5, 2026; Shares voting/represented: 17,275,798 (68.8%).
- Director election vote totals (For / Against / Abstain/Withheld):
- Kevin Brian Cox: 10,084,499 / 0 / 1,540,604
- David N. Keys: 9,956,546 / 0 / 1,668,557
- David May: 10,015,873 / 0 / 1,609,230
- Laurie Weisberg: 9,843,283 / 0 / 1,781,820
- Auditor ratification (Proposal 2): TAAD, LLP ratified — 15,872,799 For / 1,389,370 Against / 13,629 Abstain.
- Approval of investor securities agreements (Proposal 3): 10,076,231 For / 1,127,018 Against / 421,854 Abstain; these approvals relate to prior 2025–2026 transactions that could result in issuance of 20%+ of common stock.
Why It Matters
- Board continuity confirmed: the four incumbent directors were reelected, so current leadership and strategy oversight remain in place.
- Auditor ratification maintains the company’s ongoing relationship with TAAD, LLP for the 2026 fiscal year, which is relevant for financial reporting continuity.
- Approval of the investor securities agreements is material because it authorizes prior transactions that involve issuing a significant portion (20% or more) of the company’s common stock—an outcome that can affect share count and potential dilution for existing shareholders.
Loading document...